University of Oxford,
(United Kingdom of Great Britain & Northern Ireland)
Risk Factors and Prevention
Pharmacology and Pharmacotherapy, Public Health and Health Economics
Jane Armitage is Professor of Clinical Trials and Epidemiology in the Nuffield Department of Population Health (NDPH) at the University of Oxford and Honorary Consultant in Public Health Medicine at the Oxford University Hospital. She joined the Clinical Trial Service Unit, now part of NDPH, in 1990 from a background in clinical medicine, with particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated a series of large-scale randomised trials including the MRC/BHF Heart Protection Study, SEARCH and HPS2-THRIVE, which are trials of lipid modification in people with or at risk of vascular disease, as well as the ASCEND trial of aspirin and fish oils in diabetes. Her main research interests are in lipids and the epidemiology of cardiovascular and other chronic disease. She is Course Director for the Oxford University Master’s in Clinical Trials starting in 2020.
Meet the trialist - ASCEND - Randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes & Randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes
Speaker : J